RecruitingNot ApplicableNCT06165367

Hyaluronan-enriched Medium and Euploid Blastocyst Transfers

Impact of Hyaluronan-enriched Medium on Pregnancy Outcomes Following Euploid Blastocyst Transfers


Sponsor

ART Fertility Clinics LLC

Enrollment

783 participants

Start Date

Jan 15, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

It has been proposed that enriching transfer media with hyaluronan (EmbryoGlue medium) improves pregnancy outcomes compared with media containing lower concentrations of this molecule. However, none of previous studies included preimplantation genetic testing for aneuploidy (PGT-A) embryos. In order to investigate the impact of this hyaluronan-enriched on pregnancy outcomes, it is essential to evaluate its efficacy on euploid-only embryo transfers. The aim of the present study is to evaluate whether a short period of exposure of euploid blastocysts to EmbryoGlue prior to and during transfer positively impact on pregnancy outcomes of frozen embryo transfer (FET) cycles.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 46 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called EmbryoGlue Medium for people with blastocysts, clinical pregnancy rate, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 46 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGEmbryoGlue Medium

Embryos will be exposed to hyaluronic-enriched media (EmbryoGlue) before and during embryo transfer


Locations(1)

ART Fertility Clinics LLC

Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06165367


Related Trials